Skip to Content

Join the 'Merkel Cell Carcinoma' group to help and get support from people like you.

Merkel Cell Carcinoma News

Related terms: cutaneous APUDoma, primary neuroendocrine carcinoma of the skin, trabecular carcinoma of the skin

Sunscreen 101

Posted 12 days ago by Drugs.com

TUESDAY, May 16, 2017 – Many people make mistakes when using sunscreen that could increase their risk of skin cancer, a new study suggests. Researchers set up free sunscreen dispensers at the Minnesota State Fair and watched as nearly 2,200 people used them. The researchers found that only 33 percent of people applied sunscreen to all exposed skin. Only 38 percent were wearing sun-protective clothing, hats or sunglasses. Also, use of the free sunscreen dispensers fell sharply on cloudy days, the researchers reported. The study was published online May 16 in the Journal of the American Academy of Dermatology. "These results highlight some of the ways people use sunscreen incorrectly," study author Dr. Ingrid Polcari said in a journal news release. She is an assistant professor in the department of dermatology at the University of Minnesota Medical School. "To get the best possible sun ... Read more

Related support groups: Basal Cell Carcinoma, Sunburn, Melanoma, Skin Cancer, Sunscreen, Melanoma - Metastatic, Squamous Cell Carcinoma, Prevention of Sunburn, History - Skin Cancer, Merkel Cell Carcinoma, Deeptan, Coppertone

Health Tip: Teach Teens About Sun Safety

Posted 8 May 2017 by Drugs.com

-- Teens enjoying carefree fun in the sun may not worry about wrinkles, sun damage or skin cancer – but they should. It's a conversation that parents should have with teens to prevent problems later. The American Academy of Pediatrics recommends talking to teens about: Staying out of the sun when its rays are strongest, between 10 a.m. and 4 p.m. Wearing light clothing with tightly-woven fabric, which helps to reflect the sun's rays. A wide-brimmed hat and sunglasses also offer protection. Applying a broad-spectrum sunscreen every day before going outdoors, and reapplying throughout the day. Make sure it's applied to the entire body, including the tops of the ears and feet. Regularly checking skin for moles that look suspicious, and pointing any out to a parent or doctor. Read more

Related support groups: Basal Cell Carcinoma, Sunburn, Melanoma, Skin Cancer, Sunscreen, Melanoma - Metastatic, Squamous Cell Carcinoma, Prevention of Sunburn, History - Skin Cancer, Merkel Cell Carcinoma, Deeptan, Coppertone

FDA Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma

Posted 24 Mar 2017 by Drugs.com

March 23, 2017 – The U.S. Food and Drug Administration today granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC), including those who have not received prior chemotherapy. This is the first FDA-approved treatment for metastatic MCC, a rare, aggressive form of skin cancer. “While skin cancer is one of the most common cancers, patients with a rare form called Merkel cell cancer have not had an approved treatment option until now,” said Richard Pazdur, M.D., acting director of the Office of Hematology and Oncology Products in the FDA’s Center for Drug Evaluation and Research and director of the FDA’s Oncology Center of Excellence. “The scientific community continues to make advances targeting the body’s immune system mechanisms for the treatment of various types of cancer. Thes ... Read more

Related support groups: Skin Cancer, Merkel Cell Carcinoma, Bavencio, Avelumab

Bavencio Approved for Rare Skin Cancer

Posted 24 Mar 2017 by Drugs.com

THURSDAY, March 23, 2017 – Bavencio (avelumab) has been approved by the U.S. Food and Drug Administration to treat a rare but aggressive form of skin cancer called Merkel cell carcinoma (MCC), the agency said Thursday in a news release. The drug, sanctioned for people 12 and older, is the first MCC treatment approved in the United States. Some 1,600 people in the U.S. are diagnosed annually with the disease. Many cases can be treated surgically, but about half of those diagnosed will have their cancers recur, and the cancer will spread (metastasize) in some 30 percent of cases, the FDA said. Bavencio targets a protein found on some cancer cells, helping the body's immune system attack these cells, the FDA said. The drug was evaluated in a clinical study of 88 people with spreading MCC. About one-third of trial participants given Bavencio had a complete or partial shrinkage of tumors, ... Read more

Related support groups: Skin Cancer, Merkel Cell Carcinoma

Many With Advanced Lung Cancer Don't Get Treatments That Might Help

Posted 20 Jan 2017 by Drugs.com

FRIDAY, Jan. 20, 2017 – Many U.S. patients with late-stage lung cancer do not receive treatments that could prolong their lives, a new study finds. Researchers at the University of California, Davis Comprehensive Cancer Center analyzed 1998-2012 data from the U.S. National Cancer Database. They found that more than one in every five patients with non-small cell lung cancer (NSCLC) – by far the leading form of the disease – did not undergo any treatment. That included chemotherapy, radiotherapy or surgery, the researchers said. Many of the untreated patients were women, elderly, minorities, low-income and uninsured, according to the research team. The researchers found that the number of untreated patients with late-stage NSCLC even rose slightly during the study period. The reasons why some patients went untreated remain unclear, the researchers said. "We were able to identify a ... Read more

Related support groups: Surgery, Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Merkel Cell Carcinoma, Malignant Pleural Effusion, Bronchogenic Carcinoma

Drug Shows Promise Against Rare, Aggressive Skin Cancer

Posted 19 Apr 2016 by Drugs.com

TUESDAY, April 19, 2016 – A newer drug that boosts the immune system's ability to kill tumor cells may help people with a rare, aggressive form of skin cancer, a preliminary study suggests. The intravenous drug, marketed as Keytruda, is already used to treat some advanced cases of melanoma, another dangerous form of skin cancer. The new study tested it against a skin tumor called Merkel cell carcinoma (MCC). Most people have probably never heard of the cancer, but MCC is deadlier than melanoma, said Dr. Paul Nghiem, a professor of medicine at the University of Washington, who led the new study. When the disease reaches an advanced stage, chemotherapy is an option – but not a good one, Nghiem said. "Chemotherapy will often shrink the cancer," he said. "But it comes back quickly, and even angrier." Plus, chemo can take a toll on the immune system. "And that's a very bad idea in these ... Read more

Related support groups: Melanoma, Skin Cancer, Melanoma - Metastatic, Keytruda, History - Skin Cancer, Merkel Cell Carcinoma

Ask a Question

Further Information

Related Condition Support Groups

Skin Cancer

Related Drug Support Groups

Bavencio, avelumab